Patent highlights: April–May 2018

In this article, brought to MedChemNet users by Pharmaceutical Patent Analyst, Hermann Mucke provides a snapshot of noteworthy recent developments in the patent literature of relevance to pharmaceutical and medical research and development.

Go to the profile of Hermann Mucke
Sep 24, 2018

Hermann AM Mucke1
1HM Pharma Consultancy, A-1160, Wien, Austria

Noteworthy recent developments in the patent literature of relevance to pharmaceutical and medical research and development, set to be published in Volume 7 Issue 5 of Pharmaceutical Patent Analyst. The full article is available to view here.




Treatment of inflammatory bowel disease with nucleoside triphosphate diphosphohydrolase, P2Y2 antagonist &/or P2Y6 antagonist

Inventors: Sévigny J, Salem M

Assignee: Université Laval (Québec, Canada)

MeSH keywords: adenosine triphosphatases/colitis; purinergic P2; ulcerative/receptors

Published: 5 April 2018


Bismuth (III) compounds & methods thereof

Inventors: Sun H, Kao RYT, Wang R, Lai TP, Zhang H, Li H

Assignee: The University of Hong Kong (Hong Kong, China)

MeSH keywords: β-lactamase NDM-1; β-lactam resistance; bismuth subcitrate

Published: 5 April 2018


HMGB1 protein inhibitors

Inventors: Kovacs B, Shahbahrami K, Nicola G

Assignee: Afecta Pharmaceuticals, Inc. (CA, USA)

MeSH keywords: HMGB1 protein; interleukins

Published: 12 April 2018


Myogenesis-inducing agent

Inventors: Hohjoh H, Fukuoka M

Assignee: National Center of Neurology and Psychiatry (Tokyo, Japan)

MeSH keywords: miR-199a, human; muscular atrophy; muscular dystrophies

Published: 19 April 2018


Methods of treating diseases associated with repeat instability

Inventors: Pearson CE, Nakamori M, Nakatani K

Assignee: The Hospital for Sick Children (Toronto, Canada); Osaka University (Osaka, Japan)

MeSH keywords: genomic instability; Huntington disease; trinucleotide repeat expansion

Published: 15 February 2018


HPPK inhibitors useful as antibacterial agents

Inventors: Ji X, Genbin S, Shaw GX

Assignee: The United States of America, as represented by the Secretary, Department of Health and Human Services (MD, USA)

MeSH keywords: antibacterial agents; diphosphotransferases

Published: 19 April 2018


Allosteric TAO inhibitors as antiparasitical & antifungal agents

Inventors: Dardonville C, De Koning HP, Ebiloma GU

Assignee: Consejo Superior de Investigaciones Científicas (Madrid, Spain); The University Court of the University of Glasgow (UK)

MeSH keywords: antifungal agents; oxidoreductases; trypanocidal agents; trypanosomiasis

Published: 26 April 2018

Back to top of page


Methods of diagnosis & treatment of Alzheimer's disease

Inventors: Zhan X, Stamova B, Sharp F

Assignee: The Regents of the University of California (CA, USA)

MeSH keywords: Alzheimer disease; Escherichia coli; lipopolysaccharides

Published: 3 May 2018


Substituted pyrido[3,4-b]indoles for the treatment of cartilage disorders

Inventors: Gretzke D, Ritzeler O, Heinelt U, Wehner V, Schmidt F

Assignee: Sanofi SA (Paris, France)

MeSH keywords: carbolines; osteoarthritis; SOX transcription factors

Published: 11 May 2018


5-HT1F receptor agonists & mitochondrial biogenesis

Inventors: Lindsey CC, Beeson CC, Schnellmann RG

Assignee: MUSC Foundation for Research Development (SC, USA); US Department of Veterans Affairs (DC, USA)

MeSH keywords: acute kidney injury; serotonin 1F receptor

Published: 11 May 2018


Sulfonamide compound as cccDNA inhibitor

Inventors: Fu Z, Zhang Y, Luo M, Chen S, Li J, Xu H, Yang L, Zhang X

Assignee: Chia Tai Tianqing Pharmaceutical Group Co. Ltd (Jiangsu, China)

MeSH keywords: circular DNAs; hepatitis B, chronic

Published: 17 May 2018


Treatment of neurodegenerative diseases

Inventors: Guerreiro da Silva S, Michel PP

Assignee: Institut du Cerveau et de la Moelle Epinière (Paris, France); Université Pierre et Marie Curie (Paris, France); Centre National de la Recherche Scientifique (Paris; France); Institut National de la Santé et de la Recherche Médicale (Paris, France)

MeSH keywords: Alzheimer disease; calcium channels; NAADP; TPC1 protein, human; Parkinson disease; TPC2 protein, human

Published: 24 May 2018


Indanylaminopyridylcyclopropanecarboxylic acids, pharmaceutical compositions & uses thereof

Inventors: Eckhardt M, Peters S, Wagner H

Assignee: Boehringer Ingelheim International GmbH (Ingelheim am Rhein, Germany)

MeSH keywords: diabetes mellitus; FFAR1 protein, human

Published: 31 May 2018

Back to top of page

Source: Mucke HAM. Patent highlights April–May 2018Pharmaceutical Patent Analyst. (Ahead of print) doi:10.4155/ppa-2018-0022 (2018) 

Go to the profile of Hermann Mucke

Hermann Mucke

CEO, H.M. Pharma Consultancy

No comments yet.